Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11709318/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841527924907311104 |
|---|---|
| author | Yoshiyuki Yokomaku Katsuji Teruya Dai Watanabe Tomoyuki Endo Rumi Minami Nao Taguchi Tali Cassidy Andrea Marongiu David Thorpe Takuma Shirasaka Shinichi Oka |
| author_facet | Yoshiyuki Yokomaku Katsuji Teruya Dai Watanabe Tomoyuki Endo Rumi Minami Nao Taguchi Tali Cassidy Andrea Marongiu David Thorpe Takuma Shirasaka Shinichi Oka |
| author_sort | Yoshiyuki Yokomaku |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b821a938adf040fc97990328da37c516 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-b821a938adf040fc97990328da37c5162025-01-15T05:30:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohortYoshiyuki YokomakuKatsuji TeruyaDai WatanabeTomoyuki EndoRumi MinamiNao TaguchiTali CassidyAndrea MarongiuDavid ThorpeTakuma ShirasakaShinichi Okahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11709318/?tool=EBI |
| spellingShingle | Yoshiyuki Yokomaku Katsuji Teruya Dai Watanabe Tomoyuki Endo Rumi Minami Nao Taguchi Tali Cassidy Andrea Marongiu David Thorpe Takuma Shirasaka Shinichi Oka Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort PLoS ONE |
| title | Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort |
| title_full | Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort |
| title_fullStr | Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort |
| title_full_unstemmed | Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort |
| title_short | Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort |
| title_sort | bictegravir emtricitabine tenofovir alafenamide b f taf in treatment naive and treatment experienced people with hiv 12 month virologic effectiveness and safety outcomes in the bicstar japan cohort |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11709318/?tool=EBI |
| work_keys_str_mv | AT yoshiyukiyokomaku bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT katsujiteruya bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT daiwatanabe bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT tomoyukiendo bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT rumiminami bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT naotaguchi bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT talicassidy bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT andreamarongiu bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT davidthorpe bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT takumashirasaka bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort AT shinichioka bictegraviremtricitabinetenofoviralafenamidebftafintreatmentnaiveandtreatmentexperiencedpeoplewithhiv12monthvirologiceffectivenessandsafetyoutcomesinthebicstarjapancohort |